Stendard closes pre-seed funding round, targets local and European expansion https://t.co/gX4p4yMzut — The Propell Group (@ThePropellGroup) June 5, 2017 #healthtech
AstraZeneca pins hopes on novel breast cancer drug https://t.co/e7dWhqPmn5 via @FT — The Propell Group (@ThePropellGroup) June 4, 2017 #healthtech
The FDA and a $1.2 billion startup are analyzing how drugs are used after approval — and it could one day change… https://t.co/DncCyXQT5l — The Propell Group (@ThePropellGroup) June 3, 2017 #healthtech
The Economist | Review and prosper via @TheEconomist https://t.co/UYZExqJHCe — The Propell Group (@ThePropellGroup) June 2, 2017 #healthtech
How artificial intelligence is revolutionizing healthcare https://t.co/OZl7phvWb8 — The Propell Group (@ThePropellGroup) June 2, 2017 #healthtech
Global Healthcare | 38 Deals, Investments & Transactions | Wk 21 – May 2017 https://t.co/OX7SAo7MPc — The Propell Group (@ThePropellGroup) June 1, 2017 #healthtech
This is why modern device engineers need a new approach to medical training – MedCity News https://t.co/Nvn4aK9Lss — The Propell Group (@ThePropellGroup) June 1, 2017 #healthtech
Theranos board: Incurious and exactly what startups don’t need – MedCity News https://t.co/iDyeEkYHo9 — The Propell Group (@ThePropellGroup) June 1, 2017 #healthtech
In partnership with corporations, government organizations, startups and key stakeholder groups,…https://t.co/UpQQ3yOD1X — The Propell Group (@ThePropellGroup) June 1, 2017 #healthtech
SGX and IMDA kickstart tech-IPO campaign, reveals funding scheme https://t.co/4GfZu0DVMx — The Propell Group (@ThePropellGroup) June 1, 2017 #healthtech